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Endobronchial Ultrasound and Extended Roles Know Thy Limitations
To the Editor:
In the December 2012 issue of CHEST , Kennedy et al 1 raise an important point about acknowledging the boundaries of endobronchial ultrasound-guided transbronchial fi ne-needle aspiration (EBUS-TBNA), citing infectious complications after sampling a nonsubsternal thyroid nodule. There are a number of issues to consider.
The fi rst is infection. Proximity to the vocal cords is likely to be an issue with oropharyngeal contamination. Substernal thyroid nodules, and avoidance of more invasive surgical excision or mediastinoscopy, may well be a better indication for an extended role of EBUS-TBNA, but more data are needed to clarify this. 2 The risks for infection in this scenario may be reduced by greater distance from the vocal cords (although the EBUS-TBNA needle is not sterile), and this might better justify EBUS-TBNA over surgical exploration.
Second, what is the best test in this situation, and who is the best trained person to do it? Radiologists (especially those with a subspecialist interest in head and neck) are very adept at sampling thyroid nodules accessible via ultrasound-guided fi ne-needle aspiration under asepsis. Moreover, it is somewhat harder to justify complications when doing a procedure that someone else is more optimally trained for.
The third issue is training. The learning curve for EBUS-TBNA is notoriously idiosyncratic and longer than previously thought, even for experienced bronchoscopists. 3 Adding in extended roles for EBUS-TBNA introduces a need to consider this in curriculum requirements and training standards. Such roles have not been addressed currently in the UK national guidelines for EBUS-TBNA. 4 As another example, a few EBUS-TBNA operators perform transesophageal endoscopic ultrasound (EUS) with bronchoscope-guided fi ne-needle aspiration (EUS-B-FNA) 5 -7 using the endobronchial ultrasound scope when full-blown EUS is not available. This also requires competency with esophageal intubation, is not covered in the EBUS-TBNA curriculum, and is not a substitute for complete EUS-guided fi ne-needle aspiration (EUS-FNA). Moreover, it has been suggested by some that such a procedure might be better performed by experienced EUS operators. 8 Again, it might be harder to justify complications when doing EUS-B-FNA as opposed to EUS-FNA by a trained EUS operator. As a counter argument, however, there may be occasions where EUS-FNA is not available (given its considerable cost) and a trained EUS-B-FNA operator could perform this as an alternative if only endobroncial ultrasound equipment is available.
In summary, there is a natural inclination, as with any innovative technology, to extend the roles of EBUS-TBNA with time, but this needs to be recognized in EBUS-TBNA curricula and training programs. Careful consideration in the light of existing 
Relationship Between Pulmonary Emphysema and Renal Function in Smokers
We read with interest the article by Chandra et al 1 in CHEST (September 2012). These authors reported that in smokers, more severe emphysema is associated with kidney dysfunction independent of the common risk factors for kidney disease. They further the development of active tuberculosis disease . noted that no prior study has investigated the relationship between kidney function and emphysema and that the mechanisms of kidney dysfunction in patients with emphysema need further investigation. Chandra and colleagues 1 studied 508 cases, assessing the severity of emphysema by CT scan and comparing the results with glomerular fi ltration rates. However, we note that from Figure 3 of their publication, only 16 patients had an emphysema percentage of Ն 20%. In this regard, we would like to call to the attention of the authors and the readership of CHEST a study published in 1988 that one of us (V. L. R.) participated in.
Pratt et al 2 examined the cause of death in a consecutive series of 1,033 autopsies and observed that chronic renal disease is a much less common cause of death in people with emphysema, as compared with those without emphysema ( P 5 .0003). The trend persisted when individuals who died of smoking-related diseases were elim inated from the analysis ( P , .0003). When only those cases with discernible emphysema were examined (n 5 272), the percent age of emphysema in patients dying of chronic renal disease was signifi cantly lower than in all other causes of death ( P , .006). The percentage of emphysema was assessed by point counting of infl ation fi xed lung specimens to determine the volume percentage of emphysema. 3 From a mechanistic perspective, Pratt et al 2 proposed that destruction of the pulmonary vascular bed in emphysema reduces the effi ciency of conversion of angiotensin I to angiotensin II. This, in turn, could interrupt, or at least ameliorate, the vicious cycle of renal injury and release of renin leading to production of angiotensin, with a resulting increase in BP and further renal injury. Thus, an individual with emphysema might be less likely to progress to fatal end-stage renal disease. These observations are also consistent with epidemiologic studies that have shown that smokers have, on average, a lower BP than that of nonsmokers. 4 We are in complete agreement with Chandra et al 1 that further studies are necessary to understand the relationship between emphysema and renal function and to explain further the discrepant fi ndings in these authors' study as compared with those of Pratt et al. 2 
